Janux Therapeutics JANX
$10.08 −$0.21 (-2.04%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $10.15 +0.69%
Open$10.11
Prev close$10.29
Day range$10.05 – $10.54
Volume1.11M
Market cap$616.73M
P/E (TTM)–
Dividend yield–
JANX Stock News
Headlines matching Janux Therapeutics or the JANX ticker, most recent first.
- A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $14 to $60
- A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $14 to $55
- Wolfe Research Initiates Janux Therapeutics(JANX.US) With Buy Rating, Announces Target Price $23
- William Blair Maintains Janux Therapeutics(JANX.US) With Buy Rating
- Stifel Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $35
- Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Janux Therapeutics Inc (JANX)
- Truist Financial Initiates Janux Therapeutics(JANX.US) With Buy Rating, Announces Target Price $26
- Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Janux Therapeutics Inc (JANX) and Progyny (PGNY)
- A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $14 to $58
- Evercore Maintains Janux Therapeutics(JANX.US) With Buy Rating, Cuts Target Price to $22 Negative
- LifeSci Capital Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $60
- JonesTrading Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $50
- Guggenheim Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $68
- A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $24 to $68
- Stifel Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $38
No comments yet — be the first to weigh in on JANX.
Sign in to join the discussion.